Author

Neemisha Jain

Observed name: N Jain

Observed institutions: East Surrey Hospital, University of Oxford, Surrey and Sussex Healthcare NHS Trust, MRC Population Health Research Unit

OpenAlex ID: A5067571551

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

2023 · PK Judge, N Staplin, et al. · The Lancet Diabetes & Endocrinology · 123

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

2023 · N Staplin, R Haynes, et al. · The Lancet Diabetes & Endocrinology · 100

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

G65(P) Antibiotic use in acute pharyngitis in children

2016 · S Habibollah, N Jain · Archives of Disease in Childhood

G470(P) Improving self-care in diabetes management during transitional care through use of technology

2016 · N Jain, A Aravamudhan · Archives of Disease in Childhood

Works count: 9

Citation count: 328

H-index: 6

I10-index: 6